Matthew J. Stubbs
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura.
Journal: Blood
Published: May 05, 2025
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).
Journal: EClinicalMedicine
Published: October 21, 2024
A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX).
Journal: Scientific reports
Published: December 19, 2023
Organisation and delivery of a dedicated multidisciplinary prone ventilation team in the intensive care unit: Strategies and lessons from COVID-19.
Journal: PloS one
Published: August 01, 2023
Recombinant ADAMTS13 in Severe Neonatal Thrombotic Thrombocytopenic Purpura.
Journal: The New England journal of medicine
Published: December 22, 2022
The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura.
Journal: British journal of haematology
Published: February 10, 2022
Vaccine-induced immune thrombocytopenia and thrombosis associated anterior ST-elevation myocardial infarction.
Journal: European heart journal. Cardiovascular Imaging
Published: August 16, 2021
Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 27, 2021
Real-world experience with caplacizumab in the management of acute TTP.
Journal: Blood
Published: June 10, 2020
Last Updated: 09/26/2026